<--- Back to Details
First PageDocument Content
Experimental cancer treatments / Medical research / Applied genetics / Oncolytic virus / Viral vector / Gene therapy / Chimeric antigen receptor / T cell / Virotherapy / Biology / Gene delivery / Molecular biology
Date: 2013-05-10 11:29:09
Experimental cancer treatments
Medical research
Applied genetics
Oncolytic virus
Viral vector
Gene therapy
Chimeric antigen receptor
T cell
Virotherapy
Biology
Gene delivery
Molecular biology

Late Breaking Abstracts Addendum Late Breaking Abstracts: Presented at the American Society of Gene & Cell Therapy’s 16th Annual Meeting, May 15-18, 2013, Salt Lake City, Utah

Add to Reading List

Source URL: www.asgct.org

Download Document from Source Website

File Size: 564,82 KB

Share Document on Facebook

Similar Documents

Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo ,

Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo ,

DocID: 1uQqF - View Document

Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile.  Photo courtesy of Dina Potter. Sunny Tree. 48

Intralesional therapy is a possible treatment option for patients with metastatic melanoma due to its good local response and tolerable adverse-event profile. Photo courtesy of Dina Potter. Sunny Tree. 48" × 60".

DocID: 1rePY - View Document

FOR	
  IMMEDIATE	
  RELEASE	
   	
   	
    

FOR  IMMEDIATE  RELEASE        

DocID: 1pOi3 - View Document

WORLD PRECLINICAL CONGRESS June 14-17, 2016  Westin Boston Waterfront, Boston, MA

WORLD PRECLINICAL CONGRESS June 14-17, 2016  Westin Boston Waterfront, Boston, MA

DocID: 1nhVB - View Document

Late Breaking Abstracts Addendum Late Breaking Abstracts: Presented at the American Society of Gene & Cell Therapy’s 16th Annual Meeting, May 15-18, 2013, Salt Lake City, Utah

Late Breaking Abstracts Addendum Late Breaking Abstracts: Presented at the American Society of Gene & Cell Therapy’s 16th Annual Meeting, May 15-18, 2013, Salt Lake City, Utah

DocID: 1gtbO - View Document